Brad Lang has over 12 years of experience in the regenerative medicine industry. As an Executive-in-Residence at BioEnterprise, Brad provides consulting to early stage pharmaceutical and biologic companies. He also serves the role of vice president of research at Convelo, a pharma company working on novel therapeutics for neurological disorders. Previously, he served as a scientist on the regenerative medicine team at Athersys, participating in the clinical advancement of its MultiStem system. Brad received his B.S. in Biology from the University of Wisconsin-Madison and Ph.D. in Neurosciences from Case Western Reserve University.